These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 17565629)

  • 41. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.
    Wong VW; Chan WK; Chitturi S; Chawla Y; Dan YY; Duseja A; Fan J; Goh KL; Hamaguchi M; Hashimoto E; Kim SU; Lesmana LA; Lin YC; Liu CJ; Ni YH; Sollano J; Wong SK; Wong GL; Chan HL; Farrell G
    J Gastroenterol Hepatol; 2018 Jan; 33(1):70-85. PubMed ID: 28670712
    [No Abstract]   [Full Text] [Related]  

  • 44. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
    Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fatty liver].
    Mizuta T; Yamamoto K
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():257-61. PubMed ID: 11838124
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.
    Caballería L; Pera G; Auladell MA; Torán P; Muñoz L; Miranda D; Alumà A; Casas JD; Sánchez C; Gil D; Aubà J; Tibau A; Canut S; Bernad J; Aizpurua MM
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):24-32. PubMed ID: 19730384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-alcoholic fatty liver disease.
    Bhala N; Usherwood T; George J
    BMJ; 2009 Jul; 339():b2474. PubMed ID: 19608620
    [No Abstract]   [Full Text] [Related]  

  • 49. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ
    Hepatology; 2012 Jun; 55(6):2005-23. PubMed ID: 22488764
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiovascular risk in the Asia-Pacific region from a nutrition and metabolic point of view: visceral obesity.
    Sullivan DR
    Asia Pac J Clin Nutr; 2001; 10(2):82-4. PubMed ID: 11710362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fatty liver: frequent and not completely harmless].
    Lang C; Georgi A; Gubler C
    Praxis (Bern 1994); 2013 Sep; 102(18):1089-101. PubMed ID: 24005067
    [No Abstract]   [Full Text] [Related]  

  • 52. [Metabolic diseases and periodontitis].
    Noack B; Fischer S
    Dtsch Med Wochenschr; 2012 Jun; 137(22):1155-7. PubMed ID: 22619010
    [No Abstract]   [Full Text] [Related]  

  • 53. [Non-alcoholic fatty liver disease].
    Wójcik K; Piekarska A
    Pol Arch Med Wewn; 2006 Feb; 115(2):172-81. PubMed ID: 17274475
    [No Abstract]   [Full Text] [Related]  

  • 54. Nonalcoholic fatty liver disease.
    Fitzgerald MA
    Nurse Pract; 2007 Feb; 32(2):24-5. PubMed ID: 17264787
    [No Abstract]   [Full Text] [Related]  

  • 55. [Non-alcoholic fatty liver: the hepatologic stakes and the metabolic stakes].
    Traverso M
    Ann Endocrinol (Paris); 2003 Dec; 64(6):478-80. PubMed ID: 15080158
    [No Abstract]   [Full Text] [Related]  

  • 56. How many deaths are caused by non-alcoholic fatty liver disease in the Asia-Pacific region?
    Wong GL; Wong VW
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):103-105. PubMed ID: 31852632
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevalence of obesity in Pacific and Indian Ocean populations.
    Collins V; Dowse G; Zimmet P
    Diabetes Res Clin Pract; 1990; 10 Suppl 1():S29-32. PubMed ID: 2286147
    [No Abstract]   [Full Text] [Related]  

  • 58. [Brief introduction of American practice guideline for the diagnosis and management of non-alcoholic fatty liver disease].
    Ding XD; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):430-1. PubMed ID: 23230594
    [No Abstract]   [Full Text] [Related]  

  • 59. Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015).
    Goh KL
    J Clin Gastroenterol; 2017 Jul; 51(6):479-485. PubMed ID: 28591070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ; ; ;
    Am J Gastroenterol; 2012 Jun; 107(6):811-26. PubMed ID: 22641309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.